Zamarin, Dmitriy
Holmgaard, Rikke B.
Ricca, Jacob
Plitt, Tamar
Palese, Peter
Sharma, Padmanee
Merghoub, Taha http://orcid.org/0000-0002-1518-5111
Wolchok, Jedd D.
Allison, James P.
Article History
Received: 29 June 2016
Accepted: 19 December 2016
First Online: 13 February 2017
Competing interests
: J.P.A. is an inventor on patents concerning targeting CTLA-4 for cancer therapy, licensed to Bristol Myers Squibb. J.P.A. and P.S. are inventors on a patent concerning targeting of ICOS, licensed to Jounce Therapeutics. D.Z., P.P., J.D.W. and J.P.A. are inventors on a patent concerning the uses of recombinant Newcastle Disease Virus for cancer therapy. The remaining authors declare no competing financial interests.